LegiPlex
AI Workspace & Legislation Tracker
Creaet A Workspace
About
Sign Up
Login
Research Tools
Keyword Search
Bill Content
Video & Transcript
Capitol Directory (Beta)
US
Us Congress US
Legislatures
2025-2026 Regular Session
Senate
Bills
SB1414
US
Us Congress Senate Bill SB1414
Overview
Activity Timeline
Authors & Sponsors
Committee Assignments
Draft Versions & Texts
Latest Draft
Compare Versions
View All
Official Action Record
Calendar
Us Congress 2025-2026 Regular Session
Us Congress Senate Bill SB1414
Introduced
4/10/25
Refer
4/10/25
Caption
Expedited Access to Biosimilars Act
Latest US SB1414 Activity
View All Events: US 2025-2026 Regular Session SB1414
Companion Bills
No companion bills found.
Previously Filed As
US SB142
Preserve Access to Affordable Generics and Biosimilars Act
US SB3934
Increasing Access to Biosimilars Act of 2023
US HB1352
Increasing Access to Biosimilars Act of 2023
US SB5459
A bill to amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.
US HB8261
Preserving Telehealth, Hospital, and Ambulance Access Act
US SB2305
Biosimilar Red Tape Elimination Act
US SB1269
INSULIN Act of 2023 Improving Needed Safeguards for Users of Lifesaving Insulin Now Act of 2023
US HB8006
Expedited Review of Products for GSP Act
US SB1120
Improved Access to Affordable Medications Act
US HB9184
Patient Access Act of 2024
Similar Bills
No similar bills found.